Rockwell Medical, Inc.
RMTI
$1.47
$0.2318.55%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -15.03% | -23.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -15.03% | -23.32% | |||
| Cost of Revenue | -14.52% | -24.54% | |||
| Gross Profit | -17.72% | -16.22% | |||
| SG&A Expenses | -12.49% | 6.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.08% | -19.50% | |||
| Operating Income | 0.81% | -162.04% | |||
| Income Before Tax | 1.52% | -100.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.52% | -100.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.52% | -100.40% | |||
| EBIT | 0.81% | -162.04% | |||
| EBITDA | 4.26% | -3,520.83% | |||
| EPS Basic | -7.88% | -43.23% | |||
| Normalized Basic EPS | 1.74% | -94.59% | |||
| EPS Diluted | -12.61% | -33.73% | |||
| Normalized Diluted EPS | 1.74% | -94.59% | |||
| Average Basic Shares Outstanding | 0.60% | 3.74% | |||
| Average Diluted Shares Outstanding | 0.60% | 3.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||